Merck to stop development of hepatitis C treatments Ruby Khatun Khatun4 Oct 2017 10:20 AM ISTU.S. drugmaker Merck & Co said on Friday it would discontinue developing an experimental drug combination for chronic hepatitis C, as competition...
VLCC acquires nutraceutical maker Wellscience Ruby Khatun Khatun31 May 2017 11:41 AM ISTNew Delhi: Beauty and wellness firm VLCC said it has acquired nutraceutical products maker Wellscience that would enable entry into the new...
Zydus Cadila gets USFDA nod to market alcohol abstinence drug Ruby Khatun Khatun29 May 2017 11:56 AM ISTNew Delhi: Drug firm Zydus Cadila has received approval from the US health regulator to market Acamprosate calcium delayed-release tablets used for...
Zydus Wellness Q4 net up 9 pc at Rs 30 cr Ruby Khatun Khatun29 May 2017 11:51 AM ISTNew Delhi: Zydus Wellness reported a 9.3 per cent increase in consolidated net profit at Rs 30.32 crore for the quarter ended March 31.The company had...
Indoco Remedies Q4 net profit down 14 pc at Rs 18 crore Ruby Khatun Khatun28 May 2017 9:27 AM ISTDrug firm Indoco Remedies reported a 14.36 per cent decline in standalone net profit at Rs 17.94 crore for the March quarter.The company had posted a...